Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bone Biologics (BBLG) Enterprise Value (2016 - 2017)

Bone Biologics has reported Enterprise Value over the past 3 years, most recently at -$690279.0 for Q4 2017.

  • Quarterly Enterprise Value fell 11.27% to -$690279.0 in Q4 2017 from the year-ago period, while the trailing twelve-month figure was -$690279.0 through Dec 2017, down 11.27% year-over-year, with the annual reading at -$690279.0 for FY2017, 11.27% down from the prior year.
  • Enterprise Value was -$690279.0 for Q4 2017 at Bone Biologics, up from -$1.6 million in the prior quarter.
  • Over five years, Enterprise Value peaked at -$620375.0 in Q4 2016 and troughed at -$4.2 million in Q1 2016.
  • The 3-year median for Enterprise Value is -$1.1 million (2015), against an average of -$1.5 million.
  • The largest YoY upside for Enterprise Value was 64.32% in 2017 against a maximum downside of 135.67% in 2017.
  • A 3-year view of Enterprise Value shows it stood at -$1.1 million in 2015, then soared by 44.37% to -$620375.0 in 2016, then fell by 11.27% to -$690279.0 in 2017.
  • Per Business Quant, the three most recent readings for BBLG's Enterprise Value are -$690279.0 (Q4 2017), -$1.6 million (Q3 2017), and -$783014.0 (Q2 2017).